Daniel A. Maxenberger
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Unknown Researcher
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Daniel A. Maxenberger's research focuses on molecular biology techniques and applications, particularly concerning genome editing technologies. He has investigated methods for optimizing recombinant Cas9 expression in bacterial strains, aiming to enhance protein purification for genome editing applications. His work also explores the delivery challenges associated with CRISPR-Cas9 genome editing for genetic disorders such as Duchenne muscular dystrophy. Maxenberger collaborates with researchers at the University of Arkansas at Fayetteville, including Christopher E. Nelson, Made Harumi Padmaswari, and Shilpi Agrawal, on shared publications. His scholarly output includes two publications with a total of 22 citations and an h-index of 2.
Metrics
- h-index: 2
- Publications: 2
- Citations: 22
Selected Publications
-
Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
Similar Researchers
Based on overlapping research topics